Connect Biopharma Holdings Ltd
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
CNTB chart
What traders are saying about $CNTB
Latest postsConnect Biopharma Holdings Ltd news
- CNTB Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares Modestly - Upward Estimate Revision
www.dars.gov.et ·
- Connect Biopharma Holdings American Depositary Shares Stock Price Forecast. Should You Buy CNTB?
StockInvest.us ·
- Down 25.4% in 4 Weeks, Here's Why Connect Biopharma Holdings (CNTB) Looks Ripe for a Turnaround
Yahoo Finance ·
- Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Stock Has Consensus Price Target of $5.88
MarketBeat ·
- Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cullinan Management (CGEM) and BeOne Medicines (ONC)
The Globe and Mail ·
- Here's Why Connect Biopharma Holdings (CNTB) Could be Great Choice for a Bottom Fisher
Yahoo Finance ·
- Connect Biopharma COPD Study Shows 81% Cut in Treatment Failures
marketbeat.com ·
- Connect Biopharma Reports Positive Phase 2 Rademikibart COPD Data, Plans FDA Talks on Phase 3 Program
investorshub.advfn.com ·
- Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
Yahoo Finance ·
- Connect Biopharma (CNTB) Misses Key Asthma Trial Goal. Can its Drug Still Move Forward?
Yahoo Finance ·
- Connect Biopharma Rademikibart Phase 2 Data Shows Lung Function Improvement but Primary Endpoint Misses Significance
investorshub.advfn.com ·
- Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
Connect Biopharma Holdings Ltd key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $64,000 | $26.0M | $0 |
| Net income | -$55.5M | -$15.6M | -$62.1M |
| Diluted EPS | $-1.00 | $-0.28 | $-1.13 |
| Total assets (year end) | $56.1M | $101.3M | $127.4M |
| Cash and equivalents (year end) | $38.3M | $78.2M | $105.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Connect Biopharma Holdings Ltd
- Ticker
- CNTB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1835268
Frequently asked questions
What exchange is Connect Biopharma Holdings Ltd listed on?
Connect Biopharma Holdings Ltd trades on the Nasdaq under the ticker symbol CNTB.
What industry is Connect Biopharma Holdings Ltd in?
Connect Biopharma Holdings Ltd is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Connect Biopharma Holdings Ltd headquartered?
Connect Biopharma Holdings Ltd's business address on file with the SEC is in San Diego, CA.
When does Connect Biopharma Holdings Ltd's fiscal year end?
Connect Biopharma Holdings Ltd's fiscal year ends on December 31.
How much revenue did Connect Biopharma Holdings Ltd report?
Connect Biopharma Holdings Ltd reported $64,000 in revenue for calendar year 2025, according to its SEC filings.